FDA Drug recall D-309-2013
Diazepam Injection, USP 5 mg/mL, 10 mL, Multiple-dose fliptop vial, RX only, HOSPIRA, INC. LAKE FOREST, IL 60045 USA, NDC 0409-3213-12
- FDA Drug
- Class II
- terminated
- Published 2013-05-08
On 2013-05-08 the FDA classified a Class II recall of Diazepam Injection, USP 5 mg/mL, 10 mL, Multiple-dose fliptop vial, RX only, HOSPIRA, INC. LAKE FOREST, IL 60045 USA, NDC 0409-3213-12 by Hospira, citing lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-309-2013 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2012-08-28 |
| Published | 2013-05-08 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Hospira |
| Distribution | US |
Product
Diazepam Injection, USP 5 mg/mL, 10 mL, Multiple-dose fliptop vial, RX only, HOSPIRA, INC. LAKE FOREST, IL 60045 USA, NDC 0409-3213-12
Reason
Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.
Identifiers
| ndc | 0409-3213-11 |
|---|---|
| ndc | 0409-3213-12 |
| code_info | Lot 17-100-EV and 17-399-EV |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-309-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.